These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

686 related items for PubMed ID: 16979812

  • 1. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    Meczekalski B, Slopien R, Warenik-Szymankiewicz A.
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of 3alpha-androstanediol glucuronide in hirsute and non hirsute women.
    Falsetti L, Rosina B, De Fusco D.
    Eur J Endocrinol; 1998 Apr; 138(4):421-4. PubMed ID: 9578510
    [Abstract] [Full Text] [Related]

  • 3. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 4. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
    Lobo RA, Goebelsmann U, Horton R.
    J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
    [Abstract] [Full Text] [Related]

  • 5. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S, Dittrich R, Binder H, Kajaia N, Hoffmann I, Maltaris T, Beckmann MW, Mueller A.
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [Abstract] [Full Text] [Related]

  • 6. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS, Thompson DL.
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [Abstract] [Full Text] [Related]

  • 7. Androstanediol glucuronide plasma clearance and production rates in normal and hirsute women.
    Greep N, Hoopes M, Horton R.
    J Clin Endocrinol Metab; 1986 Jan; 62(1):22-7. PubMed ID: 3940268
    [Abstract] [Full Text] [Related]

  • 8. Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone.
    Mueller A, Dittrich R, Cupisti S, Beckmann MW, Binder H.
    Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):182-7. PubMed ID: 16705550
    [Abstract] [Full Text] [Related]

  • 9. [The clinical value of 3 alpha-androstanediol-glucuronide in hirsute women].
    Joura EA, Sator MO, Geusau A, Zeisler H, Söregi G, Huber JC.
    Wien Klin Wochenschr; 1997 Dec 12; 109(23):919-21. PubMed ID: 9487606
    [Abstract] [Full Text] [Related]

  • 10. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
    Liou TH, Yang JH, Hsieh CH, Lee CY, Hsu CS, Hsu MI.
    Fertil Steril; 2009 Dec 12; 92(6):1960-5. PubMed ID: 18980763
    [Abstract] [Full Text] [Related]

  • 11. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
    Toscani M, Migliavacca R, Sisson de Castro JA, Spritzer PM.
    Metabolism; 2007 Jul 12; 56(7):992-7. PubMed ID: 17570263
    [Abstract] [Full Text] [Related]

  • 12. Assessment of insulin resistance in the idiopathic hirsutism.
    Sarac F, Saygili F, Ozgen G, Tuzun M, Yilmaz C, Kabalak T.
    Gynecol Obstet Invest; 2007 Jul 12; 63(3):126-31. PubMed ID: 17057397
    [Abstract] [Full Text] [Related]

  • 13. Is there a role for insulin resistance in nonobese patients with idiopathic hirsutism?
    Abdel Fattah NS, Darwish YW.
    Br J Dermatol; 2009 May 12; 160(5):1011-5. PubMed ID: 19298279
    [Abstract] [Full Text] [Related]

  • 14. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF, Li X, Zhu MW.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct 12; 41(10):684-8. PubMed ID: 17199924
    [Abstract] [Full Text] [Related]

  • 15. The androgenic profile of women with non-insulin-dependent diabetes mellitus.
    Tok EC, Ertunc D, Evruke C, Dilek S.
    J Reprod Med; 2004 Sep 12; 49(9):746-52. PubMed ID: 15493567
    [Abstract] [Full Text] [Related]

  • 16. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.
    Yilmaz M, Karakoç A, Törüner FB, Cakir N, Tiras B, Ayvaz G, Arslan M.
    Gynecol Endocrinol; 2005 Sep 12; 21(3):154-60. PubMed ID: 16335907
    [Abstract] [Full Text] [Related]

  • 17. Plasma selenium levels in Turkish women with polycystic ovary syndrome.
    Coskun A, Arikan T, Kilinc M, Arikan DC, Ekerbiçer HÇ.
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun 12; 168(2):183-6. PubMed ID: 23490536
    [Abstract] [Full Text] [Related]

  • 18. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
    Fenkci SM, Fenkci V, Oztekin O, Rota S, Karagenc N.
    Hum Reprod; 2008 Jul 12; 23(7):1602-6. PubMed ID: 18378560
    [Abstract] [Full Text] [Related]

  • 19. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
    Vural B, Ozkan S, Bodur H.
    J Obstet Gynaecol Res; 2007 Apr 12; 33(2):166-73. PubMed ID: 17441890
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
    Bertoli A, Fusco A, Magnani A, Marini MA, Di Daniele N, Gatti S, Lauro R.
    Exp Clin Endocrinol Diabetes; 1995 Apr 12; 103(1):15-20. PubMed ID: 7621099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.